This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This builds on the essential contributions at sites from clinicalresearchcoordinators, who focus on patient recruitment and enrollment, maintaining regulatory compliance, and study coordination and communication. Finally, we should provide training and resources to help sites maintain compliance.
We often hear that clinicalresearch professionals ‘accidentally happened upon’ this career path,” adds Lisa Lionetti-Freutel, CCRC, ClinicalResearchCoordinator at Renown Health. “Once here, appropriate onboarding and training programs are key to retention.” “We
It wasn’t just the resignation of yet another clinicalresearchcoordinator (CRC) that Christina Brennan, MD, CCRC, vice president for clinicalresearch at Northwell Health, had to contend with earlier this year. between 2016 and 2026.
That’s part of the reason why Sara Abbassi, MBBS, MSPH, a clinicalresearchcoordinator (CRC) at Wellnext LLC and ACRP member, says that educating patient advocacy groups about clinicalresearch is a critical component of the profession.
Regulatory Compliance: Ensuring compliance with regulatory requirements is essential but can add to the budget. Costs associated with obtaining necessary approvals, Institutional Review Board (IRB) fees, and ensuring adherence to Good Clinical Practice (GCP) guidelines should be accounted for. Best Practices 3.1
In recognition of October being Breast Cancer Awareness Month , ACRP recently went behind the scenes with a clinicalresearchcoordinator on the study team for a bold Cleveland Clinic investigation of a vaccine aimed at preventing triple-negative breast cancer (TNBC), the most aggressive and lethal form of the disease.
Discussing the modernization of clinical trials in light of the pandemic and even larger, ongoing trends, David Burrow, PharmD, JD, Director, Office of Scientific Investigations, Office of Compliance, Center for Drug Evaluation and Research, U.S.
That’s part of the reason why Sara Abbassi, MBBS, MSPH, a clinicalresearchcoordinator (CRC) at Wellnext LLC and ACRP member, says that educating patient advocacy groups about clinicalresearch is a critical component of the profession.
“The technology burden at sites has become increasingly frustrating for our staff,” says Lydia Beaudette, MSc, ACRP-PM, MBA(c), director of growth and strategic partnerships at Centricity Research. A Site Network’s Take on Optimizing Tech.
In areas with large Latino populations, it’s essential to have clinicalresearchcoordinators, data managers, and principal investigators—among other professionals—who understand the cultural nuances and can build relationships. One major development is the expansion of clinical trials into Latin America.
In recognition of October being Breast Cancer Awareness Month , ACRP recently went behind the scenes with a clinicalresearchcoordinator on the study team for a bold Cleveland Clinic investigation of a vaccine aimed at preventing triple-negative breast cancer (TNBC), the most aggressive and lethal form of the disease.
Contreras: I was a clinicalresearch director with more than 20 years of broad experience encompassing different functional areas, including clinical, operational, regulatory, budget, compliance, site management, data management, and supplies in Phases I–IV of clinical trials development.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content